Perihilar intrahepatic cholangiocarcinoma
MONDO:0044788An intrahepatic cholangiocarcinoma that arises from the intrahepatic large bile ducts.
Also known as: perihilar ICC, perihilar bile duct carcinoma, perihilar intrahepatic cholangiocarcinoma, perihilar cholangiocarcinoma
2986 clinical trials for this condition and its sub-types, 25 tagged with Perihilar intrahepatic cholangiocarcinoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
Bile duct cancer trial halted after just one patient
Disease control Stopped earlyThis phase II trial tested a combination of chemotherapy infused directly into the liver (HAIC) plus two immunotherapy drugs (atezolizumab and bevacizumab) given before and after surgery for high-risk bile duct cancer. The goal was to see if this approach could shrink tumors and …
Phase 2 • Sponsor: Peking University • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Cancer combo trial halted early: what we know
Disease control Stopped earlyThis phase 2 trial tested two drugs—ulixertinib and hydroxychloroquine—in 47 people with advanced gastrointestinal cancers that have certain genetic mutations (MAPK pathway). The goal was to see if the combination could shrink tumors. However, the study was terminated early, so t…
Phase 2 • Sponsor: BioMed Valley Discoveries, Inc • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC